J&J seeks emergency use for Covid-19 vaccine, FDA advisory panel is next February 5, 2021 Auto Bot BioPharma, biopharma nl, Coronavirus (COVID-19), FDA, Johnson & Johnson, Vaccine 0 Johnson & Johnson’s Covid-19 vaccine offers storage and distribution advantages compared to mRNA vaccines, and is the only single-shot vaccine to reach late-stage testing. The next stop is a Feb. 26 FDA advisory panel meeting.